Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort

Peer Review reports

Original Submission
7 Mar 2018	Submitted	Original manuscript
3 May 2018	Reviewed	Reviewer Report - Allison Hodge
3 Jul 2018	Reviewed	Reviewer Report - Reviewer 2
3 Aug 2018	Author responded	Author comments - Danja Sarink
Resubmission - Version 2
3 Aug 2018	Submitted	Manuscript version 2
Publishing
2 Oct 2018	Editorially accepted
22 Oct 2018	Article published	10.1186/s12885-018-4887-3

Back to article page